![GA731000: Fmoc-Thr((Ac)3-Fuc-α-L)-OH Pack Size:250 mg 5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosyl)onicacid]-(2→6)-(β-D-galactopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranoside](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/GA731000_71cf1b33-0244-4ff9-93ff-28906b951c35.svg?v=1700861620)
Pay in 4 interest-free payments of $37.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosyl)onicacid]-(2→6)-(β-D-galactopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranoside
O-{2-acetamido-3-O-(2
C39H68N4O18S / 913
the innermost residue of all N-linked glycans
β-D-GalNAc-Hexyl-NH-Cbz
GA731000: Fmoc-Thr((Ac)3-Fuc-α-L)-OH Pack Size:250 mg 5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosyl)onicacid]-(2→6)-(β-D-galactopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosideC31H35NO12 613. 61 An Fmoc protected L threonine building block carrying an L fucose residue, designed for solid phase peptide synthesis (SPPS) of glycopeptides. The N Fmoc group is removed under standard base conditions (piperidine) during chain elongation, while the free carboxylic acid is available for coupling to the growing resin bound peptide. The sugar hydroxyl groups are protected as three acetate esters (Ac3), which keep the glycan inert
